Jane Henney impresses during FDA Commissioner hearings but appointment may be delayed until next year
This article was originally published in Clinica
Executive Summary
From her management style to such controversial topics as off-label use and pre-emption, there was much for the device industry to like in what Jane Henney, the Clinton administration candidate for FDA Commissioner, had to say at her confirmation hearing last week.